Highest-materiality recent filing
American Healthcare REIT closes 13.25M share forward offering for senior housing acquisition
Closed public offering of 13,250,000 shares of common stock on Aug 12, 2026.
Aggregate purchase price $873M for 745 units across CA, MD, NY, VA; deposits $8.73M non-refundable.
American Healthcare REIT Q2 NFFO $0.54, raises FY 2026 guidance; Same-Store NOI +13.2%
GAAP net income $30.6M ($0.16/diluted); NFFO $0.54/diluted for Q2 2026.
American Healthcare REIT CEO Danny Prosky retires; Jeff Hanson named permanent CEO
Danny Prosky retired as CEO/President effective July 21, 2026; continues as director and advisor.
American Healthcare REIT closes public offering of 14M shares on forward basis
Closed offering of 14,000,000 shares of common stock on a forward basis on May 22, 2026.
American Healthcare REIT Q1 NFFO $0.50 (+30% YoY); raises FY2026 guidance
GAAP net income $23.7M ($0.13/diluted share); NFFO $0.50/diluted share, up >30% YoY.
American Healthcare REIT enters new ATM equity program for up to $1.75B
New ATM Sales Agreement with 11 agents for up to $1.75B of common stock.
American Healthcare REIT Q4 GAAP net income $10.8M, NFFO $0.46/sh; guides FY2026 NFFO $1.99-$2.05
Q4 GAAP net income $10.8M ($0.06 diluted EPS); full year 2025 net income $69.8M ($0.42 diluted EPS).
CEO Danny Prosky takes medical leave; Chairman Jeffrey Hanson named interim CEO
CEO Danny Prosky on medical leave effective Feb 3, 2026 due to a recent medical event.
American Healthcare REIT closes public offering of 8.1M shares in forward sale
Closed public offering of 8,100,000 shares on November 24, 2025, via forward sale agreement with RBC Capital Markets.
American Healthcare REIT Q3 2025: GAAP EPS $0.33, NFFO $0.44, raises FY guidance
GAAP net income $55.9M ($0.33/share); NFFO $0.44/share.
American Healthcare REIT launches $1B ATM equity offering program
New ATM program allows sale of up to $1B in common stock through multiple agents.
American Healthcare REIT Q2 NFFO $0.42; raises FY 2025 guidance, SS NOI growth 13.9%
GAAP net income $9.9M ($0.06 EPS); NFFO $0.42 per diluted share.
American Healthcare REIT Q1 NFFO $0.38; raises FY25 guidance on strong NOI growth
GAAP net loss $6.8M ($0.04/diluted); NFFO $0.38/diluted.
AHR Q4 NFFO $0.40/sh; FY25 guidance NFFO $1.56-$1.60; same-store NOI +21.6%
Q4 GAAP net loss $(0.21)/sh; NFFO $0.40/sh. FY24 GAAP net loss $(0.29)/sh; NFFO $1.41/sh.
American Healthcare REIT establishes $500M ATM equity offering program
Up to $500M of common stock may be sold through BofA, Barclays, Citigroup, Morgan Stanley and other agents.
American Healthcare REIT Q3 NFFO $0.36/share; raises FY2024 NFFO guidance to $1.40-$1.43
GAAP net loss $3.1M ($0.03 diluted EPS); NFFO $0.36 per diluted share.
Closed public offering of 20,010,000 shares on Sep 20, 2024; underwriters' option exercised in full.
American Healthcare REIT Q2 net income $2.9M; raises full-year NFFO and NOI guidance
GAAP net income of $2.9M ($0.01 diluted EPS) vs net loss of $11.9M in Q2 2023.
American Healthcare REIT Q1 GAAP EPS $(0.04), NFFO $0.30; same-store NOI +13%
GAAP net loss $(0.04)/share; NFFO $0.30/share for Q1 2024.
AHR Board remains neutral on unsolicited mini-tender at $9.07, 34% below market
CMG Partners offers $9.07/share for up to 225,000 Class T and I shares vs. NYSE close $13.79.
GAAP net loss $(0.42) per share Q4, $(1.08) FY2023; NFFO $0.38 Q4, $1.40 FY2023.
Board neutral on Comrit tender offer at $5.23/share; declares Q1 $0.25 dividend
Comrit amended mini-tender to $5.23/share (from $13.15), extended to Mar 31; AHR stock closed at $13.80 on Mar 14.
AHR amends credit facility to $1.15B, repays $721M debt, updates occupancy and acquisition
Credit facility: $600M revolver (matures Feb 2028) and $550M term loan (matures Jan 2027), replacing 2022 facility.
American Healthcare REIT closes NYSE IPO of 64.4M shares at $12.00, nets $717.6M
Closed public offering of 64.4M shares at $12.00/share; net proceeds $717.6M used to reduce outstanding debt.
AHR launches public stock offering; webcast for existing stockholders on Feb 12
On Jan 29, 2024, AHR launched a public offering of common stock in connection with a proposed NYSE listing.
Option to purchase remaining 48% membership interest in Trilogy REIT Holdings for $240.5M–$260M cash, depending on closing date, plus possible supplemental payment up to ~$21M.
On April 6, 2023, Harold H. Greene, Gerald W. Robinson and J. Grayson Sanders, independent directors of American Healthcare REIT, Inc. (the “Company”), notified the Company of their respective intent to retire from the Company’s Board of Directors effective as of June 14, 2023.
On April 6, 2023, Harold H. Greene, Gerald W. Robinson and J. Grayson Sanders, independent directors of American Healthcare REIT, Inc. (the “Company”), notified the Company of their respective intent to retire from the Company’s Board of Directors effective as of June 14, 2023.
On April 6, 2023, Harold H. Greene, Gerald W. Robinson and J. Grayson Sanders, independent directors of American Healthcare REIT, Inc. (the “Company”), notified the Company of their respective intent to retire from the Company’s Board of Directors effective as of June 14, 2023.
increased the size of our Board to 12 members and appointed Marvin R. O’Quinn and Valerie Richardson to fill the two outstanding vacancies on our Board effective January 10, 2023.
increased the size of our Board to 12 members and appointed Marvin R. O’Quinn and Valerie Richardson to fill the two outstanding vacancies on our Board effective January 10, 2023.
On August 30, 2022, our board of directors, or our Board, increased the size of our Board to ten members and appointed Scott A. Estes to fill the outstanding vacancy on our Board and serve as a director of our company and a member of the audit committee of our Board, or our Audit Committee.
Mathieu B. Streiff informed our board of directors of his intention to transition from his position as Chief Operating Officer to Executive Vice President effective August 1, 2022, and then to retire from that position effective January 1, 2023 .
Mathieu B. Streiff informed our board of directors of his intention to transition from his position as Chief Operating Officer to Executive Vice President effective August 1, 2022, and then to retire from that position effective January 1, 2023 .
our board of directors appointed Gabriel M. Willhite, age 41 , as our Chief Operating Officer effective August 1, 2022.
the Company assumed from GAHR III the Offer Letters dated October 1, 2021 for Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff and Brian S. Peay.
the Company assumed from GAHR III the Offer Letters dated October 1, 2021 for Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff and Brian S. Peay.
the Company assumed from GAHR III the Offer Letters dated October 1, 2021 for Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff and Brian S. Peay.
Max materiality 0.85 · Median 0.60 · Most common event other_material